Interní Med. 2003; 5(9): 471-473

Očkování proti virovým hepatitidám - aktuální problém

MUDr. Petr Urbánek CSc
IV. interní klinika VFN a 1. LF UK, Praha

Keywords: vaccination, viral hepatitis A, viral hepatitis B, viral hepatitis C.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Urbánek P. Očkování proti virovým hepatitidám - aktuální problém. Interní Med. 2003;5(9):471-473.

V přehledném článku jsou rozebrány možnosti postexpoziční profylaxe a aktivní imunizace nejdůležitějších virových hepatitid.

Vaccination against viral hepatitis - recent topic

The possibilities of postexposure prophylaxis and active immunization against the most significant viral hepatitis are discussed in this paper.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Armstrong GL, Bell BP. Hepatitis A virus infection in the United States: Model-based estimates and implications for childhood immunization. Pediatrics 2002; 109 (5): 839-845. Go to original source... Go to PubMed...
    2. Averhoff FM, Moyer LA, Woodruff BA, et al. Occupational Exposures and Risk of Hepatitis B Virus Infection Among Public Safety Workers. J Occup Environ Med 2002; 44: 591-596. Go to original source... Go to PubMed...
    3. Beltrami EM, Williams IT, Shapiro CN, et al. Risk and management of blood-borne infections in health care workers. Clin Micro Rev 2000; 13: 385-407. Go to original source... Go to PubMed...
    4. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR - Morbidity & Mortality Weekly Report 1999; 48(RR-12): 1-37.
    5. Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States 1982-1998: Implications for vaccination programs. J Infect Dis 2002; 185 (6): 713-719. Go to original source... Go to PubMed...
    6. Mast EE, Alter MJ, et al. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999; 17 (13-14): 1730-1733. Go to original source... Go to PubMed...
    7. Thorpe LE, Ouellet LJ, Levy JR, et al. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. Journal of Infectious Diseases. 2000; 182 (6): 1588-1594. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.